First Time Loading...

Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.37 USD 2.87%
Updated: May 2, 2024

Kamada Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kamada Ltd
Revenue Peer Comparison

Comparables:
CLGN
B
BLRX
URGN
ENTX
B
BONS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Revenue
$142.5m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Revenue
$11m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
N/A
B
BioLine RX Ltd
TASE:BLRX
Revenue
$4.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Revenue
$82.7m
CAGR 3-Years
91%
CAGR 5-Years
136%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Revenue
₪0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Kamada Ltd's Revenue?
Revenue
142.5m USD

Based on the financial report for Dec 31, 2023, Kamada Ltd's Revenue amounts to 142.5m USD.

What is Kamada Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Kamada Ltd have been 2% over the past three years , 4% over the past five years , and 7% over the past ten years .